During the past decade, Center of Hope at Renown Medical Center conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 21 clinical trials were completed, i.e. on average, 175% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 10 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center of Hope at Renown Medical Center" #1 sponsor was "National Cancer Institute (NCI)" with 13 trials, followed by "Gynecologic Oncology Group" with 7 trials sponsored, "GOG Foundation" with 4 trials sponsored, "ImmunoGen, Inc." with 3 trials sponsored and "Aravive, Inc." with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center of Hope at Renown Medical Center" #1 collaborator was "NRG Oncology" with 11 trials as a collaborator, "National Cancer Institute (NCI)" with 11 trials as a collaborator, "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 4 trials as a collaborator, "GOG Foundation" with 3 trials as a collaborator and "Gynecologic Oncology Group" with 3 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Center of Hope at Renown Medical Center" are "Ovarian Serous Adenocarcinoma" (7 trials), "Primary Peritoneal Serous Adenocarcinoma" (7 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (6 trials), "Fallopian Tube Mucinous Adenocarcinoma" (6 trials) and "Fallopian Tube Transitional Cell Carcinoma" (6 trials). Many other conditions were trialed in "Center of Hope at Renown Medical Center" in a lesser frequency.

Most popular intervention types in "Center of Hope at Renown Medical Center" are "Drug" (29 trials), "Other" (24 trials), "Biological" (11 trials), "Radiation" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (18 trials), "Laboratory Biomarker Analysis" (17 trials), "Quality-of-Life Assessment" (13 trials), "Carboplatin" (11 trials) and "Bevacizumab" (8 trials). Other intervention names were less common.

The vast majority of trials in "Center of Hope at Renown Medical Center" are 30 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Center of Hope at Renown Medical Center". undefined are not yet recruiting, 1 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Center of Hope at Renown Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Center of Hope at Renown Medical Center, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".